Variation in thyroid tests in pregnancy. Autoimmune thyroiditis
Conditions
Interventions
Treatment - Drugs
Sponsors
Shiraz Univercity of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Inclusion criteria: willingness to participate in the study; aged 18 years or older; at 26- 28 weeks gestation based on ultrasound; alive and singleton fetus; without a history of cesarean section; without a history of any disease; free of complication in present pregnancy; Exclusion criteria: cancellation of continuing the cooperation by the participants; taking vitamin D supplements less than 8 weeks
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TSH level. Timepoint: Befor intervention and first 24 hours after birth. Method of measurement: ELISA.;T4 level. Timepoint: Befor intervention and first 24 hours after birth. Method of measurement: ELISA.;Anti TPO antibody. Timepoint: Befor intervention and first 24 hours after birth. Method of measurement: ELISA.;Anti TG antibody level. Timepoint: Befor intervention and first 24 hours after birth. Method of measurement: ELISA. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Mohammad Hossien Dabbaghmanesh
Shiraz University of Medical Sciences
Outcome results
None listed